From Nasdaq Inc.:

The Zacks Research Daily presents top analysts’ favorite stocks. New research reports include Amazon.com, Inc. (AMZN), Berkshire Hathaway Inc. (BRK.B), and Eli Lilly and Company (LLY). Amazon.com shares gained +75.7% over the past year. They’re being backed by strong Prime momentum, solid content portfolio, and strong correlation with third-party sellers. Berkshire Hathaway has outperformed its industry, growing its float, and is excelling in many non-insurance businesses. Eli Lilly has shown +63.8% growth in the past year. Sales of Verzenio, Trulicity, Taltz, and Mounjaro are boosting revenues. New drugs Zepbound and Mounjaro have gained crucial approvals, but rising pricing pressure could hurt top-line performance. Other notable reports today include JPMorgan Chase & Co. (JPM), Costco Wholesale Corporation (COST), and T-Mobile US, Inc. (TMUS). Director of Research Sheraz Mian heads the Zacks Equity Research department and is a highly regarded earnings expert.

Amazon (AMZN) is thriving with solid Prime momentum and growing AWS adoption. They’re also doing well in the global market and with small and medium businesses but face headwinds from inflation, geopolitical tensions, and foreign currency.

Berkshire Hathaway (BRK.B)’s success has come from a large property and casualty insurance market, non-insurance businesses, and steady capital. They’re struggling with catastrophe loss exposure and capital expenditure.

Eli Lilly (LLY) showed +63.8% growth last year. High demand for drugs like Verzenio and Taltz is boosting revenues, but there are challenges in meeting strong demand for incretin products and rising pricing pressure. JPMorgan Chase (JPM) employs high rates, loan growth, and branch expansion efforts to bolster earnings, whereas Costco (COST) relies on growth strategies and strong membership trends. T-Mobile (TMUS) harnesses ultra-capacity 5G network to grow margin and focuses on developing advanced 5G use cases to boost profitability. Wells Fargo (WFC) aims to generate returns through cost savings and fee income improvements, while FedEx (FDX) faces shipping volume-related weakness. Utility company Exelon (EXC) benefits from a $31.3B investment to strengthen transmission and distribution lines, and there’s growing demand from medical devices for STERIS.
General Electric’s (GE) Aerospace segment and Regeneron’s (REGN) Dupixent and oncology portfolio are performing, while Williams-Sonoma (WSM) benefits from efficient business processes. There are also concerns for SM Energy (SM) regarding declining return on invested capital and high debt exposure, as well as challenges for ATI owing to industrial downturn. Keysight Technologies (KEYS) faces demand softness in commercial communications and electronic industrial solutions, combined with integration risks.



Read more: Top Research Reports for Amazon.com, Berkshire Hathaway & Eli Lilly